[1]
L.-D. Azoulay, X. Waintraub, J. Haroche, Z. Amoura, and F. Cohen Aubart, “Factors associated with implantable cardioverter defibrillators appropriate therapy in cardiac sarcoidosis: a meta-analysis: Implantable cardioverter defibrillators in cardiac sarcoidosis”, Sarcoidosis Vasc Diffuse Lung Dis, vol. 37, no. 1, pp. 17–23, Mar. 2020, doi: 10.36141/svdld.v37i1.8271.